| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |